FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.125
-0.115 (-9.27%)
At close: Feb 21, 2025, 4:00 PM
1.130
+0.005 (0.44%)
After-hours: Feb 21, 2025, 6:50 PM EST
FibroBiologics Employees
FibroBiologics had 10 employees as of December 31, 2023. The number of employees increased by 3 or 42.86% compared to the previous year.
Employees
10
Change (1Y)
3
Growth (1Y)
42.86%
Revenue / Employee
n/a
Profits / Employee
-$1,777,900
Market Cap
39.47M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 10 | 3 | 42.86% |
| Dec 31, 2022 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 122,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
FBLG News
- 17 days ago - FibroBiologics to Host In-Person Analyst Day to Provide Research & Development Updates - GlobeNewsWire
- 7 weeks ago - FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing - GlobeNewsWire
- 7 weeks ago - D. Boral Capital Served as Exclusive Placement Agent to FibroBiologics, Inc. (Nasdaq: FBLG) in connection with its $25.0 Million Financing - GlobeNewsWire
- 2 months ago - FibroBiologics Announces $25 Million Financing - GlobeNewsWire
- 3 months ago - FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly - GlobeNewsWire
- 3 months ago - FibroBiologics Files Patent Application Covering Reduction of Blood Clots Associated with Instant Blood-Mediated Inflammatory Reaction (IBMIR) in Cell-Based Therapeutics - GlobeNewsWire
- 3 months ago - FibroBiologics Reports Third Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 4 months ago - FibroBiologics Announces Updates for Novel Artificial Thymus Organoid Technology - GlobeNewsWire